Company
United StatesPublic company, NASDAQ: NXLNEXALIN TECHNOLOGY INC. (NASDAQ: NXL), Houston, TX – FDA Inspections
Inspection records and compliance data for NEXALIN TECHNOLOGY INC. in Houston, Texas. 2 FDA inspections on record, 1 Form 483, last inspected March 10, 2023. Publicly traded as NASDAQ: NXL.
Company Profile
This profile covers NEXALIN TECHNOLOGY INC. based in Houston, Texas, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 1
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 1
- Warning letters
- 0
First inspected February 20, 2020. Last inspected March 10, 2023.
Most cited issue areas
- Design control - no procedures1 inspection
- Design validation - software validation not performed1 inspection
- Evaluation of suppliers, contractors, etc., requirements1 inspection
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| March 10, 2023 | Not classified | Medical Devices & Rad Health | 1199414 |
| February 20, 2020 | VAI | Medical Devices & Rad Health · Compliance: Devices | 1118298 |
FDA documents
People (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
NEXALIN TECHNOLOGY INC.
Stock ticker
NXL
Exchange
NASDAQ
Share price
$1.49
Market cap
$1.8M
Price as of
November 13, 2026
FEI Number
3014498660
Address
1776 Yorktown St Ste 550, Houston, Texas 77056, United States
Country
United States
ID: 3cda8b7b-b766-4b8a-aa59-6f8cec791005